Amgen Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 9 | $3.88 | $3.88 | $3.88 |
| Q2 2024 | 7 | $4.98 | $4.99 | $4.98 |
| Q3 2024 | 16 | $4.90 | $5.42 | $5.11 |
| Q4 2024 | 12 | $5.45 | $5.45 | $5.45 |
| Q1 2025 | 9 | $4.69 | $4.69 | $4.69 |
| Q2 2025 | 8 | $5.36 | $5.36 | $5.36 |
| Q3 2025 | 8 | $5.36 | $5.36 | $5.36 |
| Q4 2025 | 13 | $5.38 | $5.38 | $5.38 |
| Q1 2026 | 8 | $4.60 | $4.60 | $4.60 |
| Q2 2026 | 7 | $4.98 | $4.98 | $4.98 |
| Q3 2026 | 7 | $4.98 | $4.98 | $4.98 |
| Q4 2026 | 12 | $4.06 | $4.06 | $4.06 |
Amgen Inc. Earnings Date And Information
Amgen Inc. last posted its earnings results on Tuesday, August 6th, 2024. The company reported $4.97 earnings per share for the quarter, missing analysts' consensus estimates of $4.98 by $0.010000000000001. The company had revenue of 8.33 B for the quarter and had revenue of 28.19 B for the year. Amgen Inc. has generated $13 earnings per share over the last year ($12.49 diluted earnings per share) and currently has a price-to-earnings ratio of 54.21. Amgen Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based on prior year's report dates.
Amgen Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2024 | Q2 2024 | $1.39 | $8.35 B | $8.33 B | ||
| 05/02/2024 | Q1 2024 | -$0.21 | $7.40 B | |||
| 02/14/2024 | Q4 2023 | $1.43 | $8.20 B | |||
| 10/31/2023 | Q3 2023 | $4.65 | $3.23 | -1.42 | $6.93 B | $6.90 B |
| 08/03/2023 | Q2 2023 | $2.58 | $6.66 B | $6.99 B | ||
| 04/27/2023 | Q1 2023 | $5.32 | $6.11 B | |||
| 02/09/2023 | Q4 2022 | $3.02 | $6.84 B | |||
| 11/03/2022 | Q3 2022 | $4.01 | $6.56 B | $6.65 B | ||
| 08/04/2022 | Q2 2022 | $2.46 | $6.53 B | $6.59 B | ||
| 04/27/2022 | Q1 2022 | $2.69 | $6.24 B | |||
| 02/16/2022 | Q4 2021 | $3.38 | $6.85 B | |||
| 11/02/2021 | Q3 2021 | $3.32 | $6.67 B | $6.71 B | ||
| 08/03/2021 | Q2 2021 | $0.81 | $6.46 B | $6.53 B | ||
| 04/27/2021 | Q1 2021 | $2.85 | $5.90 B | |||
| 02/08/2021 | Q4 2020 | $2.78 | $6.63 B | |||
| 10/28/2020 | Q3 2020 | $3.45 | $6.39 B | $6.42 B | ||
| 07/28/2020 | Q2 2020 | $3.07 | $6.19 B | $6.21 B | ||
| 04/30/2020 | Q1 2020 | $3.09 | $6.16 B | |||
| 02/12/2020 | Q4 2019 | $2.87 | $6.20 B | |||
| 10/29/2019 | Q3 2019 | $3.29 | $5.63 B | $5.74 B |
Amgen Inc. Earnings: Frequently Asked Questions
-
When is Amgen Inc.'s earnings date?
Amgen Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, October 30th, 2024 based off last year's report dates.
-
How can I listen to Amgen Inc.'s earnings conference call?
The conference call for Amgen Inc.'s latest earnings report can be listened to online.
-
How can I read Amgen Inc.'s conference call transcript?
The conference call transcript for Amgen Inc.'s latest earnings report can be read online.
-
How much revenue does Amgen Inc. generate each year?
Amgen Inc. (:AMGN) has a recorded annual revenue of $28.19 B.
-
How much profit does Amgen Inc. generate each year?
Amgen Inc. (:AMGN) has a recorded net income of $28.19 B. Amgen Inc. has generated $12.56 earnings per share over the last four quarters.
-
What is Amgen Inc.'s price-to-earnings ratio?
Amgen Inc. (:AMGN) has a price-to-earnings ratio of 54.21 and price/earnings-to-growth ratio is -3.2.
